(1S,2S)-2-(3-bromophenyl)cyclopropanecarboxylic acid CAS:2165565-11-5

(1S,2S)-2-(3-bromophenyl)cyclopropanecarboxylic acid holds promise in medicinal chemistry as a scaffold for developing potential drug candidates targeting specific molecular targets or disease pathways. Researchers can explore its pharmacological properties by assessing its enantiomeric purity and studying its interactions with biological systems to evaluate its therapeutic potential. The compound's chiral nature may be leveraged to design selective pharmaceutical agents with improved efficacy and reduced side effects. In organic synthesis, this compound can serve as a key intermediate for accessing structurally diverse molecules through asymmetric transformations or derivatization reactions. Its incorporation into synthetic pathways allows for the construction of complex molecular frameworks for studying structure-activity relationships or designing new chemical entities with tailored properties. By utilizing its stereochemistry and reactivity, researchers can advance synthetic methodologies and contribute to the development of innovative compounds for various scientific and industrial applications. Overall, (1S,2S)-2-(3-bromophenyl)cyclopropanecarboxylic acid showcases versatility and potential in advancing drug discovery efforts, organic synthesis endeavors, and chemical innovation, underscoring its significance in promoting scientific knowledge and pharmaceutical advancements.